University of Michigan — Innovation Partnerships (Accelerate Blue Fund)

Ann Arbor, Michigan, United StatesFounded 2019

innovationpartnerships.umich.edu/ventures LinkedIn

Biotech & Life Sciences Healthcare Hardware & Semiconductors Climate & Energy Manufacturing

University of Michigan's Innovation Partnerships Ventures team manages the Accelerate Blue Fund, an evergreen early-stage venture fund that exclusively invests in startups licensed from University of Michigan research. It also launched the Michigan University Innovation Capital Fund in 2024 to support pre-seed startups across Michigan's public universities.

37% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (2 deals in the last 12 months vs 4 prior). Average disclosed round size is $38.0M (across 21 rounds with reported amounts).

Find people at University of Michigan — Innovation Partnerships (Accelerate Blue Fund) on Goldilocks AI

Portfolio

Fund Size

$15.6M

Top Stage

Series B

Last 12 Mo

Team

Dave Repp

Director of Ventures and Managing Director of the Accelerate Blue Fund

Alexandra Srnka

Assistant Director, Business Development

Alexi Pierce

Assistant Director, Communications

Amanda Sorensen

Director of Operations

Anthony Licavoli

Associate Director of Compliance and Patent Administration

Anupam Jhingran

Associate Director of Licensing, Therapeutics

Aparna Bubna

Associate Director of Licensing

Ashwathi Iyer

Director of Software and Content Licensing and Research Partnerships

Chris Fick

Director of Corporate and Foundation Research Alliances

Denise Graves

Commercialization Program Director, MTRAC Transportation

Don Manfredi

Associate Director of Ventures and Fund Manager

Hilary Bond

Assistant Director, Strategic Contracting

Portfolio Breakdown

Stage Distribution

Sector Distribution

Investment Activity

DealsAvg Round Size

Portfolio

27 investments

Company	Round	Amount	Valuation	Date	Role
Sygaldry	Series A	$105M	—	Apr 2026
Genomenon	Unknown	$6M	—	Jan 2026
Skeletalis	Seed	$8M	—	Nov 2025
CCourage Therapeutics	Seed	$7.8M	—	May 2025
Rescale	Series D	—	—	Apr 2025	—
MemryX	Series B	$44M	—	Mar 2025
Stoke	Series C	$260M	—	Jan 2025
X Energy	Series C	—	—	Oct 2024	participant
Confo Therapeutics	Series B	—	—	Jan 2024
Genomenon	Unknown	$5.5M	—	Jan 2024
Stoke	Series B	$100M	—	Oct 2023	participant
Genomenon	Series B	$20M	—	Jan 2022
Stoke	Growth	$100M	—	Dec 2021	participant
Akadeum Life Sciences	Series B	$17.5M	—	Oct 2021	participant
MemryX	Series A	—	—	Jan 2021
Genomenon	Series A	$5.3M	—	Jan 2021
Confo Therapeutics	Series A	—	—	May 2019
BlueWillow Biologics	Series A	$10M	—	May 2018	lead
VViewPoint Therapeutics	Series B	$35M	—	Mar 2018
Ecovia Renewables	Seed	$1M	—	Jan 2015
CROSSBAR, INC.	Series C	$25M	—	Jan 2014	—
X Energy	Series C	—	—	—	—
CROSSBAR, INC.	Series D	$35M	—	—
GripFusion	Seed	$4M	—	—
Fibarcode	Pre-Seed	$500K	—	—